Trajectory of adolescent cannabis use on addiction vulnerability
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The adolescent brain is a period of dynamic development making it vulnerable to environmental factors such as drug exposure. Of the illicit drugs, cannabis is most used by teenagers since it is perceived by many to be of little harm. This perception has led to a growing number of states approving its legalization and increased accessibility. Most of the debates and ensuing policies regarding cannabis were done without consideration of its impact on one of the most vulnerable population, namely teens, or without consideration of scientific data. We provide an overview of the endocannabinoid system in relation to adolescent cannabis exposure and provide insights regarding factors such as genetics and behavioral traits that confer risk for subsequent addiction. While it is clear that more systematic scientific studies are needed to understand the long-term impact of adolescent cannabis exposure on brain and behavior, the current evidence suggests that it has a far-reaching influence on adult addictive behaviors particularly for certain subsets of vulnerable individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“d CB1R and CB2R (Gerard et al., 1991; Griffin et al., 2000; Matsuda et al., 1990; Munro et al., 1993).”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · cited 2×
“d CB1R and CB2R (Gerard et al., 1991; Griffin et al., 2000; Matsuda et al., 1990; Munro et al., 1993).”
BackgroundD 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 2×
“The CB1R is one of the most abundant G-protein-coupled receptor in the brain (Herkenham et al., 1990, 1991a) and is Gi/o-coupled, suppressing neurotransmitter release (Howlett et al., 2002).”
BackgroundHerkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 2×
“The CB1R is one of the most abundant G-protein-coupled receptor in the brain (Herkenham et al., 1990, 1991a) and is Gi/o-coupled, suppressing neurotransmitter release (Howlett et al., 2002).”
BackgroundIdentification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101 · cited 1×
“…(PET) evidence has consistently demonstrated that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug selfadministration…”
BackgroundGlass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · cited 1×
“The expression of CB1R is most pronounced within the basal ganglia, cerebellum, cerebral cortex, hippocampus and amygdala (Biegon and Kerman, 2001; Glass et al., 1997; Herkenham et al., 1990, 1991b; Mailleux et al., 1992; Pettit et al., 1998; Wang et al., 2003) (Fig.”
BackgroundCannabis use and mental health in young people: cohort study.
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 4×
“The CB1R is highly abundant in the prefrontal cortex, primarily localized on large cholecystokinin interneurons (Marsicano and Lutz, 1999), but molecular and functional evidence suggest that CB1R is also present in a subset of pyramidal neurons (Hill et al., 2007; Marsicano and Lutz, 1999; Matsuda…”
BackgroundInfluentialVolkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916 · cited 1×
“…(PET) evidence has consistently demonstrated that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug selfadministration…”
BackgroundCannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
Tsuang, M. T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., True, W., Lin, N., Toomey, R., & Eaves, L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.967 · Cited by 710
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674 · cited 2×
“…that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug selfadministration vulnerability (Morgan et al., 2002; Nader et al., 2006).”
BackgroundGerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 2×
“…abundant in the prefrontal cortex, primarily localized on large cholecystokinin interneurons (Marsicano and Lutz, 1999), but molecular and functional evidence suggest that CB1R is also present in a subset of pyramidal neurons (Hill et al., 2007; Marsicano and Lutz, 1999; Matsuda et al., 1993).”
BackgroundHikida, T., Kimura, K., Wada, N., Funabiki, K., & Nakanishi, S. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.011 · Cited by 592
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579
Cannabis use and psychosocial adjustment in adolescence and young adulthood
Fergusson, D. M., Horwood, L. J., & Swain‐Campbell, N. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00103.x · Cited by 563
Cannabis use and later life outcomes
Fergusson, D. M., & Boden, J. M. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02221.x · Cited by 526
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys
Nader, M. A., Morgan, D., Gage, H. D., Nader, S. H., Calhoun, T. L., Buchheimer, N., Ehrenkaufer, R., & Mach, R. H. (2006) · Nature Neuroscience · doi:10.1038/nn1737 · Cited by 481 · cited 2×
“…that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug selfadministration vulnerability (Morgan et al., 2002; Nader et al., 2006).”
BackgroundHeinz, A., Siessmeier, T., Wrase, J., Hermann, D., Klein, S., Grüsser-Sinopoli, S. M., Flor, H., Braus, D. F., Buchholz, H. G., Gründer, G., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1783 · Cited by 408 · cited 2×
“…emission tomography (PET) evidence has consistently demonstrated that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug…”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Gifford, A., Hitzemann, R., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1440 · Cited by 406 · cited 1×
“…(PET) evidence has consistently demonstrated that subjects with substance abuse have less available D2R in the striatum (Heinz et al., 2004; Volkow et al., 2001, 2004, 1999; Wang et al., 1997), findings that animal models have shown to be linked to enhanced drug selfadministration…”
BackgroundStress-related factors in cannabis use and misuse: Implications for prevention and treatment
Hyman, S. M., & Sinha, R. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.08.005 · Cited by 344 · cited 4×
“…users are generally characterized by apathy, loss of goal-motivated behavior and negative mood states, and dependent subjects report more negative affect, neuroticism, aggressivity and impulsivity (Dorard et al., 2008; Hyman and Sinha, 2009; JutrasAswad et al., 2012; Zvolensky et al., 2007).”
BackgroundInfluentialPhytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · cited 1×
“In addition, cannabinoids provide medicinal benefits (Hermanson and Marnett, 2011; Hill et al., 2012) in contrast to tobacco and alcohol, which have no medical indications.”
BackgroundD2R striatopallidal neurons inhibit both locomotor and drug reward processes
Durieux, P. F., Bearzatto, B., Guiducci, S., Buch, T., Waisman, A., Zoli, M., Schiffmann, S. N., & de Kerchove d'Exaerde, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2286 · Cited by 297
The risks for late adolescence of early adolescent marijuana use
Brook, J. S., Balka, E. B., & Whiteman, M. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.10.1549 · Cited by 225 · cited 2×
“…older adolescents in regard to adjustment in transition from adolescence to young adulthood, education attainment, employment, delinquency and ability to conform to adult role (Brook et al., 1999a, 1999b; Fergusson and Boden, 2008; Fergusson et al., 2002; Lynskey et al., 2003; Tucker et al., 2006).”
BackgroundCannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212
Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A. L., & Gessa, G. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.006 · Cited by 194
Candidate genes for cannabis use disorders: findings, challenges and directions.
Agrawal, A., & Lynskey, M. T. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02504.x · Cited by 128
Tyndale, R. F., Payne, J. I., Gerber, A. L., & Sipe, J. C. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30491 · Cited by 117 · cited 1×
“Thus far, genes encoding CB1R (CNR1) and the fatty acid amide hydrolase (FAAH), an enzyme responsible for the hydrolysis of the eCB anadamide, have been shown tomodulate cannabis dependence risk (Agrawal et al., 2009; Hopfer et al., 2006; Tyndale et al., 2007).”
Background
Cited by
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Self-citationLong-Term Effects of Cannabis on Brain Structure
Battistella, G., Fornari, E., Annoni, J.-M., Chtioui, H., Dao, K., Fabritius, M., Favrat, B., Mall, J.-F., Maeder, P., & Giroud, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.67 · Cited by 342
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects
Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-19.2019 · Cited by 218
Self-citationBoumparis, N., Loheide-Niesmann, L., Blankers, M., Ebert, D. D., Korf, D., Schaub, M. P., Spijkerman, R., Tait, R. J., & Riper, H. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.016 · Cited by 110
Tóth-Király, I., Morin, A. J. S., Hietajärvi, L., & Salmela-Aro, K. (2021) · Child Development · doi:10.1111/cdev.13525 · Cited by 95
Metadata
- Authors
- Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras-Aswad, D.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 76
- Pages
- 416-424
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2163168204
- Cited by
- 153
- References
- 32
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.